From solo companion-animal clinics to specialty referral hospitals: how veterinary practices are valued, financed, and sold in a market now dominated by corporate consolidators like VCA, NVA, Thrive, and BluePearl.

3-12xEBITDA multiple

60%SBA financed

$500K-$15MTransaction range

90-150dAvg. close

Benchmark reference

EBITDA margin22-32%

Staff expense %30-36%

Medical supplies %16-22%

Facility / rent %6-10%

Revenue per FTE DVM$400-650K

Active client count1,200-2,500

New clients / month40-80

DSCR minimum1.25x

Practice Overview & Market Context

Overview

Veterinary M&A has been one of the most active consolidation stories in healthcare services. Corporate consolidators -- VCA (Mars), NVA (JAB), Thrive (TSG), BluePearl (Mars), Southern Vet Partners, AmeriVet -- have acquired over 25% of U.S. practices, pushing multiples to levels unimaginable a decade ago. A well-run multi-DVM urban practice now attracts 6-8x EBITDA; specialty hospitals command 9-12x.

Value is driven by EBITDA after normalizing DVM compensation to market-rate associate salary ($130-180K per FTE). The market is genuinely two-tiered: corporate buyers pay full multiples for scalable, multi-DVM practices; individual DVMs using SBA finance solo clinics at 3-5x SDE. Specialty and emergency hospitals command the highest multiples due to scarcity of boarded specialists and inelastic demand.

Value accelerators

Associate DVMs on staff -- 2+ DVMs = scalable, reduces owner-dependency dramatically

Specialty services -- surgery, ultrasound, laser, dermatology increase revenue per visit

Growth trajectory -- 10%+ revenue CAGR signals expanding market demand

Real estate ownership -- owned building adds collateral and a parallel exit value

Modern equipment -- digital X-ray, dental, ultrasound, in-house labs

10+ year lease -- corporate buyers require lease certainty for integration ROI

Value discounts

Single-DVM dependency -- corporate buyers apply heavy key-person discount if owner does 90%+ of production

Mixed practice -- large + small animal narrows the buyer pool significantly

Below-market fees -- pricing upside noted, but signals margin compression risk

Short lease term -- under 5 years remaining is a dealbreaker for most corporate buyers

Deferred equipment maintenance -- aging X-ray, dental units, anesthesia = post-close CapEx

🐾

The two-market reality in veterinary M&A

The same $1M-revenue GP practice can receive radically different offers: Corporate: 5-7x EBITDA, fast close, full cash, associate agreement required. Individual DVM: 3-4x SDE, SBA financing, slower, more seller involvement. Knowing which market you are targeting -- and optimizing for it -- is the most important pre-sale decision.

Veterinary PracticeFinancing & Valuation

Practice Overview & Market Context

Veterinary Practice
Financing & Valuation